Item 5.07 Submission of Matters to a Vote of Security Holders.

On February 22, 2021, we held a special meeting of stockholders of our company.



     1.   approved the agreement and plan of merger, dated as of December 6, 2020
          among CounterPath, Alianza, Inc. and CounterPath Merger Sub, Inc., and
          the transactions contemplated thereby; and

     2.   approved the adjournment of the meeting if necessary or appropriate in
          the view of the CounterPath board of directors to solicit additional
          proxies if there are not sufficient votes at this Meeting to approve the
          Merger Transaction;


The final voting results for each of the proposals submitted to a vote of the stockholders are set forth below.

Approval of the Merger Transaction

At the meeting, the stockholders voted on the approval of the Merger Transaction with the following votes:



   For    Against Withheld/Abstain Non-Votes
4,525,852 23,724        595           Nil


In addition, the votes were re-tabulated under applicable Canadian securities laws while excluding those holders of CounterPath common stock whose votes are required to be excluded pursuant to Part 8 of Multilateral Instrument 61-101, with the following votes:



   For    Against Withheld/Abstain Non-Votes
4,245,908 23,724        595           Nil


Approval of the Adjournment Proposal

At the meeting, the stockholders voted on the approval of the Adjournment Proposal with the following votes:



   For    Against Withheld/Abstain Non-Votes
4,520,527 28,903        741           Nil



--------------------------------------------------------------------------------


                                     - 4 -


Item 7.01 Regulation FD Disclosure.

A news release dated February 23, 2021 is furnished herewith.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this current report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 News Release dated February 23, 2020

--------------------------------------------------------------------------------


                                     - 5 -

© Edgar Online, source Glimpses